Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Cushman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The American Journal of Cardiology|August 28, 2014
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)Omid Fatemi, Eugene Yuriditsky, Costas Tsioufis, et al.
Diabetes, Obesity & Metabolism|October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trialYou-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Blood Pressure|July 7, 2007
Exceptional early blood pressure control rates: the ACCOMPLISH trialKenneth Jamerson, George L Bakris, Björn Dahlöf, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The American Journal of Cardiology|August 28, 2014
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)Omid Fatemi, Eugene Yuriditsky, Costas Tsioufis, et al.
Diabetes, Obesity & Metabolism|October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trialYou-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Blood Pressure|July 7, 2007
Exceptional early blood pressure control rates: the ACCOMPLISH trialKenneth Jamerson, George L Bakris, Björn Dahlöf, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
Pageof 2